Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$2.31 USD
-0.17 (-6.85%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $2.28 -0.03 (-1.30%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Bio-Path Holdings, Inc. [BPTH]
Reports for Purchase
Showing records 101 - 119 ( 119 total )
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Bio-Path Holdings, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: ZENG G